About
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for central nervous system disorders including depression, migraine, agitation due to Alzheimer's disease, narcolepsy, and fibromyalgia.
Explore Axsome Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.